Home / Courses / MPH5512
Capella University — MPH Program

MPH5512: Principles of Epidemiology

A complete guide to Capella's MPH5512 — study design papers, outbreak investigation writing, bias and confounding analysis, Bradford Hill criteria, epidemiological measures, tips, and expert help.

Graduate Level Master of Public Health Epidemiology & Research Methods APA 7th Edition

MPH5512 develops the analytical foundation that makes public health a science rather than a collection of well-intentioned opinions. Epidemiology — the study of the distribution and determinants of health and disease in populations — provides the methods for establishing that exposures cause health outcomes, quantifying the magnitude of risk, identifying the populations most affected, and evaluating the effectiveness of interventions. Every evidence-based public health practice is built on epidemiological evidence, and every MPH graduate must be able to read, interpret, and critically evaluate that evidence.

What MPH5512 covers

Epidemiological measures of frequency and association are the building blocks of all epidemiological analysis. Prevalence (the proportion of a population with a condition at a given time) and incidence (the rate of new cases developing in a population over time) are the fundamental frequency measures. The distinction matters clinically and for public health program design: a high-prevalence condition that is rarely fatal requires a different intervention approach than a low-prevalence condition with high case fatality. Measures of association — relative risk (the ratio of incidence in exposed to unexposed), odds ratio (the cross-product approximation of relative risk used in case-control studies), hazard ratio (the time-varying relative risk from survival analysis), and attributable risk (the proportion of cases in the exposed group attributable to the exposure) — quantify the relationship between exposure and outcome and are the measures through which epidemiology establishes whether risk factors cause disease.

Epidemiological study designs range in their ability to establish causal relationships. Cross-sectional studies measure exposure and outcome simultaneously in a defined population — they can establish prevalence and identify associations but cannot establish temporal sequence. Case-control studies identify people with the outcome (cases) and matched or representative people without the outcome (controls) and compare their prior exposure histories — they are efficient for rare outcomes and excellent for hypothesis generation but vulnerable to recall bias. Cohort studies follow exposed and unexposed groups over time to compare incidence of outcomes — they establish temporal sequence, measure incidence directly, and are more resistant to bias than case-control studies, but are expensive and time-consuming. Randomized controlled trials randomly assign participants to exposure (intervention) or control conditions — they are the gold standard for establishing causal efficacy with the strongest control of confounding, but are often infeasible or unethical for epidemiological risk factor research.

Bias and confounding are the central threats to validity in epidemiological research. Selection bias occurs when the study sample is not representative of the population of interest in ways that distort the exposure-outcome relationship. Information bias (including recall bias and measurement error) occurs when exposure or outcome data are inaccurately measured. Confounding occurs when an extraneous variable is associated with both the exposure and the outcome and distorts the apparent relationship between them — the classic example being the healthy worker effect, where employed people appear healthier than the general population not because employment is protective but because people with serious illnesses are less likely to be employed.

Key topics you write about in MPH5512

Common writing assignments in MPH5512

Epidemiological study design paper

The most technically demanding assignment asks students to design an epidemiological study to investigate a specific public health research question — the relationship between a specific exposure and a specific health outcome in a defined population. The paper justifies the choice of study design (cohort vs. case-control vs. cross-sectional, and why), defines the study population and sampling strategy, operationalizes the exposure and outcome measures, identifies the primary threats to validity (selection bias, information bias, and confounding), and describes the analytic approach. Papers that recommend a study design without justifying why that design is appropriate for the specific research question, or that fail to identify the major validity threats and how the study design addresses them, do not meet the graduate epidemiology standard.

Epidemic investigation paper

Students apply the CDC's ten-step outbreak investigation framework to a specific outbreak scenario — a foodborne illness cluster, a healthcare-associated infection outbreak, a respiratory illness cluster in a community, or a historic outbreak case study. The paper establishes the case definition, applies descriptive epidemiology (person, place, and time characterization of the cases), generates hypotheses about the exposure source and transmission mechanism, selects the appropriate analytic study design to test the hypothesis, interprets the analytic results, identifies the outbreak source and transmission pathway, and recommends control measures. Outbreak papers that describe the investigation steps without applying them sequentially to the specific outbreak scenario data do not demonstrate the applied epidemiological reasoning the course develops.

Causality assessment paper

Students apply the Bradford Hill criteria to assess the evidence for a causal relationship between a specific exposure and health outcome — air pollution and cardiovascular mortality, lead exposure and neurodevelopmental outcomes, physical activity and type 2 diabetes incidence, tobacco smoke and lung cancer. The paper systematically applies each criterion — strength of association, consistency, specificity, temporality, biological gradient, plausibility, coherence, experimental evidence, and analogy — to the available evidence and reaches a conclusion about the strength of the causal argument. Causality papers that only apply the criteria the evidence clearly supports (strength, consistency) without critically assessing the criteria the evidence does not address (specificity, analogy) are incomplete.

Need help with your MPH5512 study design paper or outbreak investigation?

Our epidemiology writers design rigorous studies, apply Bradford Hill criteria, and conduct outbreak investigations with the methodological precision Capella's MPH rubric requires.

Get Expert Help

Writing tips for MPH5512

Justify study design choice with validity trade-offs, not convenience

The most common error in MPH5512 study design papers is selecting a study design because it is familiar or because it avoids the most complicated methods, rather than because it is the most appropriate design for the specific research question. The appropriate study design depends on: the frequency of the outcome (rare outcomes favor case-control designs; common outcomes can use cross-sectional or cohort designs), the incubation or latency period (long latency between exposure and outcome favors cohort designs), the ability to establish temporal sequence (only cohort designs and RCTs measure incidence prospectively), the ethical feasibility of exposure assignment (only permissible for interventions), and the available resources and timeframe. For each design choice, explicitly state the alternative designs considered and why the chosen design is preferable for this specific research question's constraints.

Apply Bradford Hill criteria critically, not just confirmatorily

Bradford Hill causality analyses fail when students only apply the criteria that support a causal conclusion while ignoring the criteria the evidence does not address. Strength of association is easy to report when an odds ratio is 3.0. But specificity is hard for most environmental exposures (PM2.5 causes respiratory, cardiovascular, and metabolic effects — not specific to one disease). Analogy is often speculative. Experiment requires RCT or natural experiment data that may not exist. A genuinely rigorous Bradford Hill analysis identifies the criteria strongly met, the criteria partially met, and the criteria not met or not assessable with current evidence — and uses that complete picture to characterize the strength of the overall causal argument. An exposure-outcome relationship that meets all eight or nine criteria is much more strongly causal than one that meets only two or three, and the paper should say so explicitly.

Define the case in every outbreak investigation paper

The case definition is the most critical methodological decision in outbreak investigation — it determines who counts as a case and therefore which people are included in the investigation. A case definition must specify: the clinical criteria (signs, symptoms, and laboratory confirmation requirements), the exposure criteria (location, time period, and sometimes specific exposures), and the classification level (confirmed, probable, or suspected). A case definition that is too sensitive (includes many symptomatic people without the disease of interest) generates false leads and obscures the true exposure-outcome relationship. Too restrictive a definition misses true cases and underestimates the outbreak's scope. Every MPH5512 outbreak paper must specify the case definition used and justify its sensitivity-specificity balance for the investigation's stage (early investigation uses a sensitive definition to capture all possible cases; the analytic study uses a more specific definition to sharpen the hypothesis test).

Why students seek help with MPH5512

MPH5512 is often the most technically demanding course in the MPH curriculum for students who come from clinical or administrative backgrounds without prior research methods training. The quantitative reasoning required — calculating odds ratios, interpreting confidence intervals, assessing bias and confounding, and evaluating study design validity — is genuinely challenging for students whose prior education emphasized practical clinical skills or organizational management rather than research methodology. Writing about epidemiological methods in a way that is technically correct and demonstrates graduate-level analytical depth takes time to develop.

The study design paper is the assignment that most frequently produces papers that are too vague — specifying a study design without detailing the specific operationalization of exposure and outcome measures, without identifying the primary confounders and how they will be addressed, and without discussing the specific validity threats the design faces. Graduate-level epidemiology writing requires this level of methodological specificity.

How GradeEssays helps with MPH5512

GradeEssays supports MPH students in MPH5512 with epidemiological study design papers, outbreak investigation analyses, and causality assessments. When you provide your research question, outbreak scenario or exposure-outcome relationship, and Capella's rubric, your writer produces methodologically rigorous work that selects and justifies study design choices with validity trade-off analysis, applies outbreak investigation methods in sequence to specific scenario data, and evaluates causal criteria with the completeness and intellectual honesty graduate epidemiology demands. All work is original and delivered with time for your review.

Get Help With MPH5512

Study design papers, outbreak investigation analyses, Bradford Hill causality assessments, epidemiological data interpretation. Share your research question or outbreak scenario and rubric for rigorous graduate epidemiology writing.

Place Your Order View All Services

Related courses

Frequently asked questions

What is the difference between incidence and prevalence?

Incidence measures new cases — the rate at which healthy people in a population develop a condition over a specified time period. The incidence rate expresses this as new cases per person-time (for example, 12 new cases per 1,000 person-years); the incidence proportion (cumulative incidence) expresses it as new cases per at-risk population over a defined follow-up period. Prevalence measures existing cases — the proportion of a population that has a condition at a specific moment in time (point prevalence) or during a specified time period (period prevalence). The mathematical relationship between incidence and prevalence depends on the duration of the condition: for conditions that are brief (quickly resolve or cause death), prevalence is low even if incidence is high; for chronic conditions that persist for years, prevalence is much higher than incidence. This distinction matters for public health: a highly prevalent condition like hypertension requires management strategies for the existing prevalent cases even as we work to reduce incidence of new cases.

What is confounding and how is it controlled in epidemiological studies?

A confounder is a variable that is associated with both the exposure and the outcome, and is not on the causal pathway between them, in a way that distorts the apparent exposure-outcome relationship. The classic example: coffee drinking is associated with lung cancer in early observational studies — but the association is confounded by tobacco smoking, which is associated with both coffee consumption and lung cancer. After controlling for smoking, coffee's apparent association with lung cancer largely disappears. Confounding can be controlled in study design through randomization (which distributes confounders equally between groups), restriction (limiting the study to a homogeneous subgroup where the confounder doesn't vary), and matching (selecting controls who match cases on known confounders). In the analysis phase, confounding is controlled through stratified analysis (examining the exposure-outcome relationship within strata defined by the confounder) or multivariable regression adjustment (statistically adjusting for confounders in a regression model).

What are the Bradford Hill criteria and how are they used?

The Bradford Hill criteria, proposed by Austin Bradford Hill in 1965, are nine considerations for evaluating whether an observed epidemiological association is likely to be causal. They are: (1) Strength of association — stronger associations (higher relative risk or odds ratio) are less likely to be entirely attributable to bias or confounding; (2) Consistency — the association should be observed across multiple studies in different populations and settings; (3) Specificity — the exposure should be associated with a specific outcome and specific exposed population; (4) Temporality — the exposure must precede the outcome (the only required criterion); (5) Biological gradient — there should be a dose-response relationship; (6) Plausibility — a biologically plausible mechanism should exist; (7) Coherence — the association should not contradict existing biological knowledge; (8) Experiment — removal of the exposure should reduce the disease; (9) Analogy — similar exposures are known to cause similar effects. No single criterion is sufficient; the criteria are evaluated collectively to characterize the strength of the causal argument.

What is sensitivity and specificity in screening test evaluation?

Sensitivity is the proportion of truly diseased individuals correctly identified as positive by a screening test — its ability to detect disease when it is present. A highly sensitive test has few false negatives and is valuable when missing a case has serious consequences (HIV screening, cancer screening). Specificity is the proportion of truly non-diseased individuals correctly identified as negative — the test's ability to correctly rule out disease in people who don't have it. A highly specific test has few false positives and is valuable when false positives lead to harmful or expensive follow-up testing. The positive predictive value (PPV) — the proportion of people who test positive who actually have the disease — depends critically on the prevalence of the disease in the tested population: the same test with the same sensitivity and specificity has a much lower PPV in a low-prevalence population than in a high-prevalence population, because there are many more true negatives to generate false positives from. This is why mass population screening for rare diseases produces many false positives even with highly specific tests.